Stay updated with breaking news from Quantum Flex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We caught up with Kevin Knopp, CEO and co-founder of 908 Devices, to discuss the main obstacles in cell and gene therapy manufacturing and how the company's recent partnership with Terumo Blood and Cell Technologies is tackling these challenges.
Operator: Hello and welcome to today's 908 Devices Third Quarter 2023 Financial Results Conference Call. My name is Jordan and I'll be coordinating your call today.
Terumo Blood and Cell Technologies, a medical tech company, and BioCentriq, a cell therapy contract development and manufacturing organization (CDMO), are working together to demonstrate the capabilities of Terumo’s automated cell and gene therapy platforms to accelerate CAR-T cell development.
Terumo Blood and Cell Technologies, a medical tech company, and BioCentriq, a cell therapy contract development and manufacturing organization (CDMO), are working together to demonstrate the capabilities of Terumo’s automated cell and gene therapy platforms to accelerate CAR-T cell development.
Samsung and Dutch-American audiovisual artist 0010x0010 will be featuring The Wall at a Museum of Contemporary Arts exhibit. - SamMobile